2m 2m 2m 2m 2m 2m 2m
CELLDEX THERAPTC (CLDX)
NASDAQ
$38.56+$0.03 (+0.07%)
Price as of Jul 14, 2026 4:50 AM EDT- $3.0BMarket Cap
- 64.94%1-Year Change
- BiotechnologyIndustry
CELLDEX THERAPTC (CLDX)
$38.56+$0.03 (+0.07%)
CLDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $38.53 | ||
Change | -$0.58 (-1.48%) | ||
Open | $38.61 | ||
High | $38.66 | ||
Low | $37.52 | ||
Previous Close | $39.11 | ||
Volume | 660,189 | ||
30-Day Average Volume | 1,403,289 | ||
1-Week Change | 1.53% | ||
1-Month Change | 23.22% | ||
1-Year Change | 64.94% | ||
3-Year Change | 2.86% | ||
5-Year Change | -13.61% | ||
Fundamentals | |||
Shares Outstanding | 78.5M | ||
Total Assets | $511.3M | ||
Market Cap | $3.0B | ||
Enterprise Value | $3.0B | ||
Period: QTR TTM FY | |||
Revenue | $15,000.00 | ||
Net Income | -$78.7M | ||
Free Cash Flow | -$67.2M | ||
EBIT | -$78.7M | ||
EBITDA | -$77.8M | ||
Net Working Capital | $407.8M | ||
EPS | -$1.18 | ||
Enterprise Value/EBITDA | -38 | ||
Enterprise Value/Revenue | 199,238 | ||
P/B | 7 | ||
P/E | -33 | ||
PEG | 0 | ||
Price/Free Cash Flow | -45 | ||
Price/Operating Cash Flow | -46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 02/11/2019 | ||
Earnings & Revenue